Results 11 to 20 of about 4,695 (214)

Edematous form of the Hemolytic Disease of the Fetus and Newborn [PDF]

open access: yesМедицинский вестник Юга России, 2019
Clinical observation of a premature newborn patient with an edematous form of the Hemolytic Disease is presented. A feature of this case is its relative rarity in view of the favorable outcome of the most severe form of hemolytic disease in an extremely ...
M. G. Pukhtinskaya   +3 more
doaj   +4 more sources

Hemolytic disease of the fetus and newborn caused by anti-E

open access: yesAsian Journal of Transfusion Science, 2013
Objective: Maternal allo-antibody production is stimulated when fetal red blood cells are positive for an antigen absent on the mother′s red cells. The maternal IgG antibodies produced will pass through the placenta and attack fetal red cells carrying ...
Adiyyatu Sa′idu Usman   +3 more
doaj   +4 more sources

Hemolytic disease of the newborn, beyond the Rhesus disease [PDF]

open access: yesRomanian Medical Journal, 2022
Hemolytic disease of the fetus and newborn is a consequence of maternal immune response to fetal red blood cells antigens inherited from the father, that the mother does not possess, stimulated by antepartum or intrapartum fetomaternal hemorrhage.
Ana Maria Huszti   +4 more
doaj   +3 more sources

Hemolytic disease of the fetus and newborn: Current trends and perspectives

open access: yesAsian Journal of Transfusion Science, 2011
The spectrum of hemolytic disease of the newborn has changed over the last few decades. With the implementation of Rhesus D immunoprophylaxis, hemolytic disease due to ABO incompatibility and other alloantibodies has now emerged as major causes of this ...
Basu Sabita   +2 more
doaj   +4 more sources

Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report [PDF]

open access: yesJournal of Medical Case Reports, 2012
Introduction Hemolytic disease of the fetus and newborn is most commonly caused by anti-D alloantibody. It is usually seen in Rhesus D (RhD)-negative mothers that have been previously sensitized.
Yousuf Rabeya   +3 more
doaj   +3 more sources

Hemolytic Disease of the Fetus and Newborn [PDF]

open access: yes, 2019
This thesis describes the pathogenesis, severity and treatment of hemolytic disease of the fetus and newborn.Sanquin Bloedvoorziening; Momenta Pharmaceuticals; Afdeling Verloskunde LUMC; Sanquin PlasmaproductenLUMC / Geneeskunde ...
Zwiers, C.
openaire   +3 more sources

Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn [PDF]

open access: yesJAMA Network Open
Importance Preventive efforts in pregnancy-related alloimmunization have considerably decreased the prevalence of hemolytic disease of the fetus and newborn (HDFN). International studies are therefore essential to obtain a deeper understanding of the postnatal management and outcomes of HDFN. Taken together with
Derek P. de Winter   +96 more
core   +10 more sources

Oblivious of the yellow world – A newborn's telltale: ABO hemolytic disease of newborn

open access: yesGlobal Journal of Transfusion Medicine, 2019
The increased destruction of fetal red cells can be immune (allo- or autoantibodies) or nonimmune (hemoglobinopathies, enzyme defects, and membrane defects) in nature and can cause shortened life span of red cells leading to hemolytic disease of the ...
Daljit Kaur   +3 more
doaj   +2 more sources

Hemolytic disease of the fetus and newborn due to multiple alloantibodies in pregnancy

open access: yesAsian Journal of Transfusion Science, 2020
Immune hemolytic disease of the fetus and newborn is a condition in which there is the premature destruction of fetal or neonatal red cells due to maternal alloantibody against red cell antigen inherited from father.
Vidushi Gupta   +2 more
doaj   +3 more sources

HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (HDFN) – CASE REPORT [PDF]

open access: yesZdravniški Vestnik, 2003
Background. Hemolytic disease of the fetus and newborn (HDFN) develops because of the passage of maternal erythrocyte alloantibodies through the placenta. These antibodies cause a reduction of the erythrocyte life span in the fetus and newborn.
Irena Bricl   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy